WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Join the Society for Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Houseweart, M. K.
Right arrow Articles by Cleveland, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houseweart, M. K.
Right arrow Articles by Cleveland, D. W.

 Previous Article  |  Next Article 

The Journal of Neuroscience, August 1, 1999, 19(15):6446-6456

Bcl-2 Overexpression Does Not Protect Neurons from Mutant Neurofilament-Mediated Motor Neuron Degeneration

Megan K. Houseweart1, 2 and Don W. Cleveland1, 2, 3, 4

1 Ludwig Institute for Cancer Research, 2 Program in Biomedical Sciences, 3 Division of Cellular and Molecular Medicine, and 4 Department of Neuroscience, University of California at San Diego, La Jolla, California 92093

Transgenic mice with a point mutation in the light neurofilament gene develop amyotrophic lateral sclerosis-like motor neuron disease characterized by selective spinal motor neuron loss, neurofilamentous accumulations, and severe muscle atrophy. To test whether the large motor neurons at risk in this disease could be protected from mutant neurofilament-mediated killing, these mice were bred to mice overexpressing the human Bcl-2 proto-oncogene. Elevated levels of Bcl-2 increased the numbers of motor and sensory axons surviving after the developmental period of naturally occurring cell death but did not greatly reduce the number of degenerating axons or protect the large motor neurons from mutant neurofilament-mediated death.

Key words: Bcl-2; amyotrophic lateral sclerosis; transgenic mice; motor neuron; cell death; neurofilament


Copyright © 1999 Society for Neuroscience  0270-6474/99/19156446-11$05.00/0


This article has been cited by other articles:


Home page
J. Neurosci.Home page
J.-M. Beaulieu, H. Jacomy, and J.-P. Julien
Formation of Intermediate Filament Protein Aggregates with Disparate Effects in Two Transgenic Mouse Models Lacking the Neurofilament Light Subunit
J. Neurosci., July 15, 2000; 20(14): 5321 - 5328.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-